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Secretory IgA is important in mucosal defense, but other, incompletely understood effectors exist. In this
issue of Cell Host & Microbe, Kamada et al. (2015) show that IgG antibodies are produced against surface
virulence factors of an intestinal attaching/effacing pathogen, bind to bacteria localized at the epithelium,
and direct their destruction by mucosal and translocated neutrophils.Infections of the gastrointestinal tract and
diarrheal disease remain one of the lead-
ing causes of morbidity and mortality in
the world, yet antibiotic treatment is often
not effective or can even exacerbate dis-
ease, and the development of vaccines
continues to be painstakingly slow. One
reason for this dismal state of affairs is
our lack of basic understanding of the
mucosal defenses the host employs,
mostly successfully, in clearing itself of
enteric pathogens acquired from contam-
inated food or water. Themucosal surface
of the gut presents special challenges
for antimicrobial defense because it con-
tends with and even actively supports a
vast microbial community whose mem-
bers are well known to greatly outnumber
host cells in the body. It is becoming
increasingly clear that the normal micro-
biota has a myriad of physiological func-
tions, so defending against and eradi-
cating all bacteria would be not only
futile, but probably detrimental, as sug-
gested by the mucosal damage and
morbidity associated with inflammatory
bowel disease. Instead, the mucosal im-
mune system needs to find the proverbial
needles-in-the-haystack and direct its de-
fenses against those needles (i.e., enteric
pathogens) without burning up the hay-
stack (i.e., the microbiota) or ruining the
farm (i.e., the intestinal tract). Secretory
IgA has long been considered the prime
adaptive system to meet this defense
challenge, as it is secreted into the lumen
in vast quantities and can neutralize
microbial antigens in a specific fashion.
However, many intestinal and other
mucosal infections can be cleared even
in the absence of IgA, strongly indicating
that other intestinal immune defenses
are equally or more important. What is
the nature of these defenses? Are they538 Cell Host & Microbe 17, May 13, 2015 ª2cellular or humoral, both, or neither?
How can they act in the unique anatomic
and physiologic conditions of the intesti-
nal tract, with much of the microbiota
located in the lumen and at the surface
in an ‘‘offshore’’ position that is not strictly
within the body bounds proper?
In this issue, Kamada et al. (2015)
provide intriguing answers to these impor-
tant questions. Their studies focus on a
bacterial model pathogen, Citrobacter ro-
dentium, which are Gram-negative bacte-
ria that form characteristic attachment
lesions at the epithelial surface of colon
and cecum in mice (Luperchio and Scha-
uer, 2001). They functionally resemble
a group of human microbes, the attach-
ing-and-effacing (A/E) pathogens, which
share the ability to adhere to the intestinal
epithelium, efface microvilli, and induce
characteristic, actin-filled membranous
pedestals, but are only minimally invasive
into the mucosa. Important members of
this group are enteropathogenic Escheri-
chia coli (EPEC), which can lead to serious
diarrheal illness in infants especially in
developing countries, and enterohemor-
rhagic E. coli (EHEC), which can cause
colitis and hemolytic-uremic syndrome
with high mortality due to the production
of Shiga toxins that damage the renal
endothelium and epithelium. Adult murine
models for EPEC andEHEC remain unsat-
isfactory, but C. rodentium is a genuine
murine pathogen, originally identified as
the cause of a veterinary disease, trans-
missible murine colonic hyperplasia,
found in large mouse colonies (Schauer
and Falkow, 1993). Given the robust and
physiologically relevant infection, and the
strong engagement of innate andadaptive
immunity,C. rodentiumhasbecomeama-
jor infectionmodel to test new ideas about
the nature and mechanisms of mucosal015 Elsevier Inc.defenses. In immunocompetent mice,
infection causes self-limiting mucosal
inflammation, characterized by crypt hy-
perplasia, goblet cell loss, epithelial cell
disruption, andmucosal thickening,which
begins to resolve within 10–14 days
postinfection and is normally cleared by
21–28 days. Studies over the last decade
have shown that bacterial clearance is
dependent on B cells, CD4+ T cells of the
Th1 and Th17 lineages, natural killer cells,
neutrophils, andmast cells (Bry and Bren-
ner, 2004; Geddes et al., 2011; Maaser
et al., 2004; Simmons et al., 2003). How-
ever, the actual effector mechanisms
had remained amystery, particularly since
the prototypic mucosal defense system,
secretory IgA, was not required for clear-
ance (Maaser et al., 2004). Pathogen-spe-
cific IgG antibodies were known to be
elicited, and then bound and transported
into the intestinal lumen by the neonatal
Fc receptor (Yoshida et al., 2006), but
how they led to bacterial clearance was
not known.
Kamada et al. (2015) now show that IgG
antibodies are produced against major
virulence factors at the bacterial surface
that are encoded in the locus of entero-
cyte effacement (LEE), a pathogenicity is-
land essential for infection and virulence.
The antibodies bind to a subset of bacte-
ria localized close to the epithelial surface
that express LEE proteins, and direct their
IgG-dependent destruction by mucosal
and translocated neutrophils. LEE pro-
teins are important for tight binding of
the bacteria to the epithelium.Most prom-
inent among LEE protein is the bacterial
adhesin intimin, which binds to the bacte-
rially encoded intimin receptor that is
translocated to epithelial cells from the
bacteria upon initial contact. As previ-
ously shown by others (Higgins et al.,
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et al., LEE proteins are critical for colo-
nization of the murine host with a conven-
tional microbiota. Interestingly, Kamada
et al. discovered that only epithelium-
attached bacteria expressed the LEE
locus, while luminal bacteria did not,
underlining that LEE proteins are impor-
tant for colonizing the epithelial niche but
appeared to be impose a fitness cost for
C. rodentium not residing in that niche.
This observation supports the broader
concept that virulence gene expression
is costly for pathogens and often limited
to locales where it provides direct sur-
vival advantages. Specific IgG was found
to bind to LEE-expressing, attached
bacteria, but very little to LEE-negative,
luminal bacteria. Furthermore, the num-
ber of LEE-expressing bacteria was
observed to decrease in parallel to the in-
duction of adaptive immunity, suggesting
that IgG binding had detrimental effects
on the bacteria, yet in vitro experiments
did not reveal any direct effects of IgG
on bacterial LEE expression or growth.
Instead, elegant experiments on bacte-
ria-host cell colocalization and in a
genetic model of neutrophil deficiency
demonstrated that IgG coating of the bac-
teria leads to their uptake by mucosal
and transmigrated neutrophils and subse-
quent killing by these cells. In other words,
the host marks with IgG the worst
bacterial culprits, those bacteria that ex-
press LEE proteins required for colonizing
a unique and potentially vulnerable
intestinal niche, and sends in its most
potent acute assassins, neutrophils, for
a mucosal or offshore excursion to selec-
tively kill them.
What about the LEE-negative bacteria?
They are not decorated by IgG, so they
should escape neutrophil-dependentkilling. They probably do avoid outright
killing, but the lack of expression of the
critical LEE virulence genes also pre-
vents them from colonizing and thus ex-
ploiting the relatively safe supraepithelial
haven. As a consequence, the LEE-
negative C. rodentium must compete
with commensal microbes in the luminal
compartment to remain in the host. This
fight they lose over time, as convincingly
demonstrated by Kamada et al. (2015) in
gnotobiotic mice colonized with LEE-defi-
cient bacteria and then given normal mi-
crobiota. Together, the findings show
nicely how the host employs a ‘‘divide-
and-conquer’’ strategy, where the most
virulent bacterial subpopulation of an
enteric pathogen is marked by virulence
factor-specific IgG and directly killed by
mucosal and transmigrated neutrophils,
and the less virulent bacterial subpopula-
tion is left to beoutcompetedby themicro-
bial commensals.
Important questions remain. Why is
the IgG response primarily directed
against LEE proteins, but not other
bacterial surface molecules? Are these
simply the most abundant surface mole-
cules, or are they more immunogenic
than others? Does it matter which spe-
cific LEE proteins are targeted by IgG,
or is total IgG binding the critical deter-
minant of presumably Fc-dependent
neutrophil phagocytosis? The answer
matters for the design of improved vac-
cines, as it affects optimal antigen selec-
tion. Where exactly is IgG required to
mediate its actions, in the intestinal
lumen or mucosa? If in the lumen, how
does it get there, solely by active trans-
port through the neonatal Fc receptor
(Yoshida et al., 2006), or by passive
leakage, perhaps secondary to epithelial
barrier disruption during the inflamma-Cell Host & Microbetory response to infection? The latter
might be a case of the pathogen digging
its own grave, but it would also question
whether a new vaccine strategy could
depend on such a potentially disruptive
mechanism. How do the findings from
germ-free mice apply to conventional
situations with normal commensals?
Finally, what are the lessons for the
design of mucosal adjuvants, a formi-
dable biological challenge and an area
of great medical urgency? The work by
Kamada et al. (2015) gives us an impor-
tant nudge toward the answers.REFERENCES
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